Skip to main content
Erschienen in: World Journal of Surgery 4/2020

06.12.2019 | Original Scientific Report

Randomized Controlled Trial on Autologous Platelet-Rich Plasma Versus Saline Dressing in Treatment of Non-healing Diabetic Foot Ulcers

verfasst von: Ahmed Elsaid, Mohammed El-Said, Sameh Emile, Mohamed Youssef, Wael Khafagy, Ayman Elshobaky

Erschienen in: World Journal of Surgery | Ausgabe 4/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

This randomized clinical trial was conducted to assess the role of platelet-rich plasma (PRP) gel as a treatment of clean non-healing diabetic foot ulcer (DFU) in comparison with regular dressing with saline as a control.

Methods

Patients with DFU were randomly assigned to one of two equal groups: group I received dressing with PRP gel and group II received regular saline dressing. The main outcomes of the study were percent reduction in the dimensions of the DFU, healing of DFU, and complications at 20 weeks of follow-up.

Results

Twenty-four patients were included to the study. The mean age of patients was 55.2 ± 6.4 years. Only three (25%) patients in group I achieved complete healing versus none of group II patients. In total, 8.3% of group I and 41.6% of group II patients did not show any response to treatment. The percent of reduction in the longitudinal and horizontal dimensions of the DFU was significantly greater in group I than group II (43.2% vs 4.1%) and (42.3% vs 8.2%), respectively. The time required to maximum healing was significantly shorter in group I than group II (6.3 ± 2.1 vs 10.4 ± 1.7 weeks, P < 0.0001).

Conclusion

The use of PRP gel as a dressing for chronic DFU resulted in a more significant reduction in the size of the ulcer when compared to regular saline dressing. Also the time to reach the point of maximal possible healing with the least wound dimensions was significantly shorter when using PRP as a dressing protocol.
Literatur
1.
Zurück zum Zitat Abbott CA, Carrington AL, Ashe H, Bath S, Every LC, Griffiths J, Ryder CH (2002) The north-west diabetes foot care study: incidence of and risk factors for new diabetic foot ulceration in a community-based patient cohort. Diabet Med 19(5):377–384CrossRef Abbott CA, Carrington AL, Ashe H, Bath S, Every LC, Griffiths J, Ryder CH (2002) The north-west diabetes foot care study: incidence of and risk factors for new diabetic foot ulceration in a community-based patient cohort. Diabet Med 19(5):377–384CrossRef
2.
Zurück zum Zitat Alexiadou K, Doupis J (2012) Management of diabetic foot ulcers. Diabetes Therapy 3(1):4CrossRef Alexiadou K, Doupis J (2012) Management of diabetic foot ulcers. Diabetes Therapy 3(1):4CrossRef
3.
Zurück zum Zitat Prompers L, Schaper N, Apelqvist J, Edmonds M, Jude E, Mauricio D, Jirkovska A (2008) Prediction of outcome in individuals with diabetic foot ulcers: focus on the differences between individuals with and without peripheral arterial disease. The EURODIALE study. Diabetologia 51(5):747–755CrossRef Prompers L, Schaper N, Apelqvist J, Edmonds M, Jude E, Mauricio D, Jirkovska A (2008) Prediction of outcome in individuals with diabetic foot ulcers: focus on the differences between individuals with and without peripheral arterial disease. The EURODIALE study. Diabetologia 51(5):747–755CrossRef
4.
Zurück zum Zitat Marx RE (2004) Platelet-rich plasma: evidence to support its use. J Oral Maxillofac Surg 62(4):489–496CrossRef Marx RE (2004) Platelet-rich plasma: evidence to support its use. J Oral Maxillofac Surg 62(4):489–496CrossRef
5.
Zurück zum Zitat Cancela AM, Lana JF, Annichino-Bizzachi JM, Belangero WD, Luzo ÂC (2014) Use of platelet-rich plasma (PRP) in treating chronic wounds. In: Lana JF, Shimojo AA, Belangero WD, Malheiros Luzo AC (eds) Platelet-rich plasma. Springer, Berlin, pp 281–288CrossRef Cancela AM, Lana JF, Annichino-Bizzachi JM, Belangero WD, Luzo ÂC (2014) Use of platelet-rich plasma (PRP) in treating chronic wounds. In: Lana JF, Shimojo AA, Belangero WD, Malheiros Luzo AC (eds) Platelet-rich plasma. Springer, Berlin, pp 281–288CrossRef
6.
Zurück zum Zitat Motolese A, Vignati F, Antelmi A, Saturni V (2015) Effectiveness of platelet-rich plasma in healing necrobiosis lipoidica diabeticorum ulcers. Clin Exp Dermatol 40(1):39–41CrossRef Motolese A, Vignati F, Antelmi A, Saturni V (2015) Effectiveness of platelet-rich plasma in healing necrobiosis lipoidica diabeticorum ulcers. Clin Exp Dermatol 40(1):39–41CrossRef
7.
Zurück zum Zitat Shan GQ, Zhang YN, Ma J, Li YH, Zuo DM, Qiu JL, Chen ZL (2013) Evaluation of the effects of homologous platelet gel on healing lower extremity wounds in patients with diabetes. Int J Low Extrem Wounds 12(1):22–29CrossRef Shan GQ, Zhang YN, Ma J, Li YH, Zuo DM, Qiu JL, Chen ZL (2013) Evaluation of the effects of homologous platelet gel on healing lower extremity wounds in patients with diabetes. Int J Low Extrem Wounds 12(1):22–29CrossRef
8.
Zurück zum Zitat Kon E, Buda R, Filardo G, Di Martino A, Timoncini A, Cenacchi A, Marcacci M (2010) Platelet-rich plasma: intra-articular knee injections produced favorable results on degenerative cartilage lesions. Knee Surg Sports Traumatol Arthrosc 18(4):472–479CrossRef Kon E, Buda R, Filardo G, Di Martino A, Timoncini A, Cenacchi A, Marcacci M (2010) Platelet-rich plasma: intra-articular knee injections produced favorable results on degenerative cartilage lesions. Knee Surg Sports Traumatol Arthrosc 18(4):472–479CrossRef
9.
Zurück zum Zitat Ahmed M, Reffat SA, Hassan A, Eskander F (2017) Platelet-rich plasma for the treatment of clean diabetic foot ulcers. Ann Vasc Surg 38:206–211CrossRef Ahmed M, Reffat SA, Hassan A, Eskander F (2017) Platelet-rich plasma for the treatment of clean diabetic foot ulcers. Ann Vasc Surg 38:206–211CrossRef
10.
Zurück zum Zitat Saldalamacchia G, Lapice E, Cuomo V, De Feo E, D’Agostino E, Rivellese AA, Vaccaro O (2004) A controlled study of the use of autologous platelet gel for the treatment of diabetic foot ulcers. Nutr Metab Cardiovasc Dis 14:395–396CrossRef Saldalamacchia G, Lapice E, Cuomo V, De Feo E, D’Agostino E, Rivellese AA, Vaccaro O (2004) A controlled study of the use of autologous platelet gel for the treatment of diabetic foot ulcers. Nutr Metab Cardiovasc Dis 14:395–396CrossRef
11.
Zurück zum Zitat Margolis DJ, Kantor J, Santanna J, Strom BL, Berlin JA (2001) Effectiveness of platelet releasate for the treatment of diabetic neuropathic foot ulcers. Diabet Care 24(3):483–488CrossRef Margolis DJ, Kantor J, Santanna J, Strom BL, Berlin JA (2001) Effectiveness of platelet releasate for the treatment of diabetic neuropathic foot ulcers. Diabet Care 24(3):483–488CrossRef
12.
Zurück zum Zitat Abegão KGB, Bracale BN, Delfim IG, Santos ESD, Laposy CB, Nai GA, Nogueira RMB (2015) Effects of heterologous platelet-rich plasma gel on standardized dermal wound healing in rabbits. Acta cirúrgica brasileira 30(3):209–215CrossRef Abegão KGB, Bracale BN, Delfim IG, Santos ESD, Laposy CB, Nai GA, Nogueira RMB (2015) Effects of heterologous platelet-rich plasma gel on standardized dermal wound healing in rabbits. Acta cirúrgica brasileira 30(3):209–215CrossRef
13.
Zurück zum Zitat Jeong SH, Han SK, Kim WK (2010) Treatment of diabetic foot ulcers using a blood bank platelet concentrate. Plast Reconstr Surg 125(3):944–952CrossRef Jeong SH, Han SK, Kim WK (2010) Treatment of diabetic foot ulcers using a blood bank platelet concentrate. Plast Reconstr Surg 125(3):944–952CrossRef
14.
Zurück zum Zitat Crovetti G, Martinelli G, Issi M, Barone M, Guizzardi M, Campanati B, Carabelli A (2004) Platelet gel for healing cutaneous chronic wounds. Transfus Apher Sci 30(2):145–151CrossRef Crovetti G, Martinelli G, Issi M, Barone M, Guizzardi M, Campanati B, Carabelli A (2004) Platelet gel for healing cutaneous chronic wounds. Transfus Apher Sci 30(2):145–151CrossRef
15.
Zurück zum Zitat Driver VR, Hanft J, Fylling CP, Beriou JM (2006) A prospective randomized controlled trial of autologous platelet-rich plasma gel for the treatment of diabetic foot ulcers. Ostomy Wound Manag 52(6):68 Driver VR, Hanft J, Fylling CP, Beriou JM (2006) A prospective randomized controlled trial of autologous platelet-rich plasma gel for the treatment of diabetic foot ulcers. Ostomy Wound Manag 52(6):68
Metadaten
Titel
Randomized Controlled Trial on Autologous Platelet-Rich Plasma Versus Saline Dressing in Treatment of Non-healing Diabetic Foot Ulcers
verfasst von
Ahmed Elsaid
Mohammed El-Said
Sameh Emile
Mohamed Youssef
Wael Khafagy
Ayman Elshobaky
Publikationsdatum
06.12.2019
Verlag
Springer International Publishing
Erschienen in
World Journal of Surgery / Ausgabe 4/2020
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-019-05316-0

Weitere Artikel der Ausgabe 4/2020

World Journal of Surgery 4/2020 Zur Ausgabe

Innovative Surgical Techniques Around the World

Minimally Invasive Pilonidal Excision: Preliminary Report

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.